STOCK TITAN

Insider sells 6,434 shares; SFM (NASDAQ: SFM) files Form 144 notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SFM notice of planned sales of Common Stock by an insider. The filing lists proposed sales of 7,404 shares and 1,656 shares (each tied to options) with an intended sale date of 04/28/2026. The filing also reports four completed sales in March 2026 totaling 6,434 shares across 03/13/2026–03/20/2026 with reported proceeds shown per trade.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 notice reporting planned option-related sales and recent open-market dispositions.

The filing lists proposed sales of 7,404 shares and 1,656 shares tied to options with an intended sale date of 04/28/2026. It also itemizes four prior sales totaling 6,434 shares executed between 03/13/2026 and 03/20/2026, with per-trade proceeds reported.

These disclosures are procedural: they provide transaction counts, dates, and cash proceeds. Cash‑flow treatment and any trading plan citation are not shown in the excerpt; subsequent filings may clarify execution method or tax treatment.

Planned sale (line 1) 7,404 shares Planned sale tied to Option Granted 03/14/2023, intended 04/28/2026
Planned sale (line 2) 1,656 shares Planned sale tied to Option Granted 03/19/2024, intended 04/28/2026
March 13, 2026 sale 275 shares Proceeds reported $21,829.45 on 03/13/2026
March 16, 2026 sale 5,280 shares Proceeds reported $426,749.66 on 03/16/2026
March 18, 2026 sale 563 shares Proceeds reported $47,007.74 on 03/18/2026
March 20, 2026 sale 316 shares Proceeds reported $26,534.99 on 03/20/2026
Form 144 regulatory
"Lists proposed sales and recent dispositions of restricted or control securities"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Option Granted financial
"Option Granted 03/14/2023 and Option Granted 03/19/2024"
Cash financial
"Sale method listed as Cash for planned sales dated 04/28/2026"
Issuer regulatory
"Designated as the seller role in the securities-to-be-sold lines"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does SFM's Form 144 report about planned sales?

It reports planned sales of 7,404 and 1,656 shares tied to options with an intended date of 04/28/2026. The notice lists the security type as Common Stock and option grant dates of 03/14/2023 and 03/19/2024.

How many shares did the insider sell in March 2026 for SFM?

The filing shows four March 2026 sales totaling 6,434 shares between 03/13/2026 and 03/20/2026. Individual trades were 275, 5,280, 563, and 316 shares with reported cash proceeds per trade.

Are the reported March 2026 sales cash transactions and what proceeds were shown?

Yes, the excerpt lists cash proceeds for each March 2026 trade: $21,829.45, $426,749.66, $47,007.74, and $26,534.99. The entries are labeled as Common stock sales with cash consideration.

Do the planned 04/28/2026 sales come from option exercises?

The filing ties the planned sales to options: one line notes Option Granted 03/14/2023 and the other Option Granted 03/19/2024, indicating the shares to be sold are option-related and the sale method is labeled as Cash in the excerpt.